NCT03860571View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

70

Participants

Timeline

Start Date

July 6, 2018

Primary Completion Date

September 24, 2018

Study Completion Date

December 13, 2018

Conditions

Normal Healthy Volunteers

Interventions

DRUG

Placebo

Oral tablet

DRUG

BT-11

Oral tablet

Trial Locations (1)

24060

Site, Blacksburg

Sponsors

Lead Sponsor

NImmune Biopharma

All Listed Sponsors

lead

NImmune Biopharma

INDUSTRY

NCT03860571 - Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers | Biotech Hunter | Biotech Hunter